Sorafenib
CAS 284461-73-0
In Stock
Sorafenib
Cat. No. STUB-API-SORAFENIBCAS 284461-73-0In Stock
Technical Data
Cat. No.STUB-API-SORAFENIB
CAS284461-73-0
Mol. FormulaC21H16ClF3N4O3
Mol. Weight464.831 g/mol
IUPAC4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide
SMILESCNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
InChIInChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31)
InChI KeyMLDQJTXFUGDVEO-UHFFFAOYSA-N
Purity—
Description
Overview
Sorofeni is a kinase inhibitor drug approved for the treatment of primary kidney cancer, advanced primary liver cancer, FLT3-ITD positive AML, and radioactive iodine resistant advanced thyroid carcinoma
Anant Labs manufacture and furnish high quality Sorafenib impurities for global markets. Our Sorafenib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
Sorafenib284461-73-0BAY 43-9006sorafenibum4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamideDTXSID7041128BAY-43-9006N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea
